Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05101070
Title S-531011 as Monotherapy and in Combination With an Immune Checkpoint Inhibitor in Advanced or Metastatic Solid Tumors (aCCeleR8-001)
Acronym aCCeleR8-001
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Shionogi Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Angeles Clinic and Research Center RECRUITING Los Angeles California 90025 United States Details
Henry Ford Health Center RECRUITING Detroit Michigan 48202 United States Details
Fox Chase Cancer Center RECRUITING Philadelphia Pennsylvania 19111 United States Details
National Cancer Center Hospital East RECRUITING Kashiwa Chiba Japan Details
Osaka University Hospital RECRUITING Suita Osaka Japan Details
National Cancer Center Hospital RECRUITING Chuo Ku Tokyo Japan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field